A. Peleg

发表

Lipopolysaccharide, a Key Molecule Involved in the Synergism between Temporins in Inhibiting Bacterial Growth and in Endotoxin Neutralization*

Maria Luisa Mangoni, Richard M. Epand, Y. Shai, 2008, Journal of Biological Chemistry.

Transient Shielding of Intimin and the Type III Secretion System of Enterohemorrhagic and Enteropathogenic Escherichia coli by a Group 4 Capsule

C. Sasakawa, S. Altuvia, M. Waldor, 2008, Journal of bacteriology.

Identification of an Escherichia coli Operon Required for Formation of the O-Antigen Capsule

S. Altuvia, I. Rosenshine, M. Saper, 2005, Journal of bacteriology.

Cycling of Etk and Etp Phosphorylation States Is Involved in Formation of Group 4 Capsule by Escherichia coli

K. Sathiyamoorthy, I. Rosenshine, M. Saper, 2012, PloS one.

A Unique Natural Human Igg Antibody with Anti-a-galactosyl Specificity

U. Galili, U Galili, E A Rachmilewitz, 2022 .

Interfering with the Dimerization of the ErbB Receptors by Transmembrane Domain-Derived Peptides Inhibits Tumorigenic Growth in Vitro and in Vivo.

Erez M. Bublil, Y. Yarden, Y. Shai, 2016, Biochemistry.

A unique natural human IgG antibody with anti-alpha-galactosyl specificity

U. Galili, E. Rachmilewitz, A. Peleg, 1984, The Journal of experimental medicine.

Anti-cytomegalovirus (CMV) IgG antibody titer in patients with risk factors to atherosclerosis

A. Peleg, A. Blum, M. Weinberg, 2003, Clinical and Experimental Medicine.

Effect of PhoP-PhoQ Activation by Broad Repertoire of Antimicrobial Peptides on Bacterial Resistance*

Y. Shai, Tal Shprung, P. Trieu-Cuot, 2011, The Journal of Biological Chemistry.